Contrast Media Market Recent Developments - Industry Report 2024
According to research report the Contrast Media Market
is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0
billion in 2019, growing at a CAGR of 3.8% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911
Growth
in the market can primarily be attributed to the rising volume of CT
and MRI examinations globally, and the rapidly growing cancer and CVD
population across the globe, increasing number of approvals of contrast
agents. Rising research activities on contrast agents & their
applications are the key areas of opportunity in this market
GE
Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and
Guerbet (France) are some of the leading players in the Contrast Media
Contrast Agent Market. Other prominent players in the market are
Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B. Chemicals
(India), Sanochemia (Austria), Taejoon Pharm (South Korea), Jodas
(India), and Magnus Health (India).
Recent Developments:
> In 2017, GE Healthcare (US) launched a new Macrocyclic MRI contrast agent, Clariscan, in Europe.
> In 2019, Bayer AG (Germany) received FDA approval for Gadavist as the first contrast agent for cardiac MRI.
>
In 2019, Guerbet Group partnered with IBM Watson Health for AI in
medical imaging to support liver cancer diagnostics, utilizing CT and
MRI imaging.
Based on type, the contrast media market is
segmented into iodinated contrast media, gadolinium-based contrast
media, barium-based contrast media, and microbubble contrast media. In
2019, the iodinated contrast media segment is estimated to account for
the largest share of the contrast media industry. The large share of
this segment can be attributed due to its high usage in CT examinations
coupled with the fact that it can be used in almost all body parts.
Based
on modality, the contrast agent market is segmented into X-ray/CT, MRI,
and ultrasound procedures. In 2019, X-ray/CT procedures segment is
expected to command the largest share of the global contrast agent
market. The large share of this segment can be attributed to the
increasing number of CT examinations across the globe, coupled with
advancements in CT imaging technologies.
Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=911
North
America, Europe, Asia Pacific, and the Rest of the World (RoW) are the
regions considered for geographic analysis of the global contrast media
market study. North American market is expected to account for the
largest share of the global Contrast Media Contrast Agent Market. The
Asia Pacific market is expected to grow at the highest CAGR in the
forecast period.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com
Comments
Post a Comment